Urinary and sexual function after robotic and laparoscopic rectal cancer surgery: a systematic review and meta-analysis.

Autor: Zhu L; Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215000, Jiangsu, China., Li X; Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215000, Jiangsu, China., Zhang H; Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215000, Jiangsu, China., Li H; Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215000, Jiangsu, China. lihangdenghehe@163.com., Shen X; Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215000, Jiangsu, China. shenxiping2022@163.com.
Jazyk: angličtina
Zdroj: Journal of robotic surgery [J Robot Surg] 2024 Jun 22; Vol. 18 (1), pp. 262. Date of Electronic Publication: 2024 Jun 22.
DOI: 10.1007/s11701-024-02019-0
Abstrakt: The purpose of the study was to compare the protective effects of robotic rectal cancer surgery (RRCS) and laparoscopic rectal cancer surgery (LRCS) on urinary and sexual function of patients. We conducted a systematic search in the PubMed, Web of Science, Cochrane Library, and Embase for studies comparing the impact of RRCS and LRCS on urinary function and sexual function. The International Prostate Symptom Score (IPSS), the five-item version of the International Index of Erectile Function (IIEF-5) and the Female Sexual Function Index(FSFI) were used to evaluate the urinary function and sexual function of patients. A total of 13 studies comprising 1964 patients were included in this meta-analysis, including 3 randomized controlled trials, 5 retrospective cohort studies, 3 prospective cohort studies, and 2 propensity score-matched studies. Nine hundred and fifty-nine patients underwent RRCS and 1005 patients underwent LRCS. Statistical analysis of the IPSS scores indicated urinary function was significantly better in the RRCS group than in the LRCS group at 3, 6 and 12 months postoperatively [mean difference (MD), - 1.06, 95% CI - 1.85 to - 0.28; and MD, - 0.96, 95% CI - 1.60 to - 0.32; and MD, - 1.09, 95% CI - 1.72 to - 0.46]. Statistical analysis of the IIEF-5 scores indicated male sexual function was significantly better in the RRCS group than in the LRCS group at 3, 6 and 12 months postoperatively (MD, 1.76, 95% CI 0.80 to 2.72; and MD, 1.83, 95% CI 0.34 to 3.33; and MD, 1.05, 95% CI 0.09 to 2.01). Statistical analysis of the FSFI scores indicated female sexual function was significantly better in the RRCS group than in the LRCS group at 6 and 12 months postoperatively (MD, 2.86; 95% CI 1.38 to 4.35; and MD, 4.19; 95% CI 1.85 to 6.54). RRCS is more favorable than LRCS in preserving the urinary and sexual function of patients with rectal cancer.
(© 2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: